Skip to main content
GutCited

Lactase Hình ảnh

11 hình ảnh từ nghiên cứu có bình duyệt

Tất cả Psyllium Husk Bifidobacterium lactis Fructooligosaccharides (FOS) Lactobacillus plantarum Peppermint Oil Pancreatic Enzymes (Pancrelipase) Curcumin Vitamin A Medium-Chain Triglycerides (MCT Oil) Galactooligosaccharides (GOS) Lactobacillus gasseri Aloe Vera (Inner Leaf Gel) Alpha-Galactosidase Vitamin D L-Glutamine Inulin Ginger Lactase Berberine Omega-3 Fatty Acids (EPA/DHA) Bovine Colostrum Zinc Bifidobacterium bifidum Butyrate (Sodium/Calcium Butyrate) Bacillus coagulans Saccharomyces boulardii Lactobacillus acidophilus N-Acetyl Cysteine (NAC) Bifidobacterium longum
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 2. Small bowel water content (SBWC) and breath hydrogen (H2) concentrations after drinking each of the drinks: glucose and fructose. The time of drinking (t = 0 min) is highlighted in the chart. Values of SBWC are mean volume (mL) ˘ s.e.m (standard
Figure 2 Chart

Small bowel water content and breath hydrogen concentrations after consuming glucose and fructose drinks are plotted over time, providing reference data for comparison with lactose challenge tests.

Lactose Intolerance in Adults: Biological Mechanism and Dietary Management.

Figure 3. Prevalence of lactose malabsorption (LM) and lactose intolerance (LI) in patients with diarrhea predominant irritable bowel syndrome (IBS-D) and controls at 10-, 20-, and 40-g lactose hydrogen breath test (HBTs). * p < 0.05; ** p < 0.01 [3
Figure 3 Chart

Prevalence of lactose malabsorption versus symptomatic lactose intolerance in IBS-D patients is compared, demonstrating that malabsorption does not invariably produce clinical symptoms.

Lactose Intolerance in Adults: Biological Mechanism and Dietary Management.

Figure 1. Bone mass throughout the life span. Bone accumulates rapidly in childhood and grows at maximal rates during puberty. Peak bone mass is reached by age 30, and then slowly decreases. Females typically accumulate less bone mass than males and rapid
Figure 5 Chart

Bone mass changes throughout the human lifespan are charted, showing rapid accumulation during childhood, peak bone mass around age 30, and subsequent gradual decline. Females typically experience accelerated bone loss after menopause, underscoring the importance of adequate calcium intake in earlier decades.

Lactose Intolerance and Bone Health: The Challenge of Ensuring Adequate Calcium Intake.

Figure 5
Figure 5 Chart

Alpha diversity indices of fecal microbiota are plotted for treated versus placebo groups, indicating whether probiotic supplementation altered overall bacterial community richness.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 6
Figure 6 Chart

Lactose tolerance test outcomes are compared between intervention groups, with symptom severity mapped against breath hydrogen concentrations.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 8
Figure 8 Chart

Fecal short-chain fatty acid concentrations are measured across treatment groups, reflecting metabolic activity changes in the gut microbiome following probiotic administration.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 3. Representation of bloating (visual analogue scale (VAS) 0–100 mm) in 23 patients at baseline (T0) and after 30 days (T30) of treatment (ZR) and placebo (PL) by spaghetti graft.
Figure 9 Chart

Individual patient trajectories for bloating severity, measured on a 0-100 mm visual analogue scale, are plotted at baseline and after 30 days for both the probiotic treatment and placebo groups.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 10
Figure 10 Chart

Symptom improvement scores for lactose-intolerant patients receiving a combined Bifidobacterium longum and Lactobacillus rhamnosus preparation are compared with placebo responses over the treatment period.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 4. Relative proportions (percent) of phylum in the fecal samples of treated patients (ZR) and those of placebo (PL) patients.
Figure 11 Chart

Relative proportions of bacterial phyla in fecal samples are compared between probiotic-treated and placebo groups, revealing shifts in gut microbiota composition following Bifidobacterium longum and Lactobacillus rhamnosus supplementation.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 12
Figure 12 Chart

Hydrogen breath test results before and after probiotic supplementation are presented, indicating alterations in lactose fermentation patterns associated with treatment.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 5. Relative proportions (percent) of genera showing significant (p < 0.05) differences between the fecal samples of treated patients (ZR) and those of placebo (PL) patients.
Figure 13 Chart

Bacterial genera showing statistically significant differences between probiotic-treated and placebo patients are depicted, highlighting specific microbial populations responsive to Bifidobacterium and Lactobacillus supplementation.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …